First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy

BACKGROUND: Combination chemotherapy (gemcitabine plus nab-paclitaxel and FOLFIRINOX) is widely used as the standard first-line treatment for pancreatic cancer. Considering the severe toxicities of combination chemotherapy, gemcitabine monotherapy (G mono) could be used as a first-line treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Sung Yong, Kim, Dong Uk, Seol, Young Mi, Kim, Suk, Lee, Nam Kyung, Hong, Seung Baek, Seo, Hyung-Il
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520790/
https://www.ncbi.nlm.nih.gov/pubmed/33024759
http://dx.doi.org/10.12998/wjcc.v8.i18.4022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520790/
https://www.ncbi.nlm.nih.gov/pubmed/33024759
http://dx.doi.org/10.12998/wjcc.v8.i18.4022

Ejemplares similares